The Supervisory Board of the National Pharmaceutical Company Farmak made a resolution to open a Representative Office in Republic of Belarus.
The resolution to open a Representative Office of Farmak in Belarus was made in view of the necessity to develop markets and increase sales volumes of medicinal products in that country.
Farmak's Representative Office in the Republic of Belarus will carry out the functions of commodity market studies, market research; will represent and protect the interests of the company in government authorities and offices, commercial and non-commercial organizations.
Farmak's Representative Offices currently operate in Republic of Uzbekistan, Republic of Kazakhstan, Russian Federation and Kyrgyz Republic.
According to the decision of economic courts of all instances (2009-2010), the name “Corvalol” (“Corvalolum”) was used exclusively by one manufacturer as the name of the medicinal product. Information that Corvalol was manufactured by 70 pharmaceutical enterprises of the USSR is not true. In the middle of 20th century, Lomonosov Kyiv Chemical and Pharmaceuti...
On October 30 the next court hearing was held in the case regarding the well-known trademark Corvalol Corvalolum. During the court hearing, after having heard the parties’ arguments and a complete and unbiased analysis of the case-file, the Economic Court ruled to dismiss the claim of Pharmaceutical Firm “Darnitsa” against the Ministry of Economic Deve...
Farmak was granted 7 awards in the contest “Best Corporate Media of Ukraine 2019” held by the Association of Corporate Media of Ukraine. The jury consisted of professionals granted the Grand Prix as the highest award to the corporate newspaper “Farmak Life” and the Company’s website. They were awarded with the title “Best Corpmedia Ukraine […]